Skip to content
DataLookout
Menu

NCT07444749

Trillium Validation Study

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 2 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Phase changed: Not specified → Not applicable Show 11 more changesShow less
    • Primary endpoint(s) modified
    • Sponsor changed: [Redacted] to Philips Clinical & Medical Affairs Global
    • Results posted: Nov 12, 2026
    • Trial status changed: Withheld → Completed
    • Enrollment changed: None → 45
    • Interventions modified
    • Trial arms changed: 0 → 2
    • Primary and study completion dates: May 28, 2026
    • Start date: Apr 21, 2026
    • Study title shortened, about 10 words
    • Collaborators expanded, about 5 words
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Median Unintentional Leak
Timeframe: During each approximately 15-day treatment period

Arms and interventions

Trillium Mask first and then AirFit F20 MaskExperimental

Participants will use Trillium for the first treatment period and AirFit F20 for the second treatment period.

AirFit F20 Mask first then Trillium MaskExperimental

Participants will use AirFit F20 for the first treatment period and Trillium for the second treatment period.

Devices: Trillium, AirFit F20

Sites

1 site in 1 country

  • Florida Lung and Sleep AssociatesFort Myers, Florida, United States